~" The object of this study was to investigate the role of the ventrolateral medullary pressor area in mediating the cardiovascular responses to experimentally induced global cerebral ischemia, and to test if excitatory amino acids or acetylcholine are the transmitters released in this brain region during these responses. The cerebral ischemic response was elicited in pentobarbital-anesthetized, artificially ventilated male Wistar rats by bilateral ligation of vertebral arteries followed by temporaD' clamping of the common carotid arteries. The pressor area was identified by microinjections of k-glutamate. Inhibition of neurons in this area by microinjections of muscimol, a ~r-aminobutyric acid receptor agonist, abolished the ischemic response, which demonstrated that this area is important in mediating these responses. Microinjections of a broad-spectrum excitatory, amino acid receptor blocker (kynurenate), of specific antagonists for N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors (injected alone or in combination), and of atropine failed to block the ischemic responses. These results indicate that: 1) the ventrolateral medullary pressor area mediates pressor responses to cerebral ischemia, and 2) excitatory amino acids or acetylcholine in this area do not mediate the cardiovascular responses to cerebral ischemia.
L-glutamate 9 kainate 9 kynurenate 9 N-methyl-D-aspartic acid 9 muscimol quisqualate ischemia amino acid acetylcholine rat C EREBRAL ischemia is encountered in many neurosurgical disorders. It is associated with sympathoexcitation which results in a pressor response, 4's~6 hereafter referred to as "cerebral ischemic response" in this paper.
Recently, a ventrolateral medullary pressor area (referred to here as "pressor area") has been identified in experimental studies on animals. 37~4:4 The neurons in this area represent the final link in the central pathways regulating cardiovascular function. In the rat, this area is located about 0.2 to 0.5 mm dorsal to the ventral surface of the medulla and is limited rostrally by the caudal end of the facial nucleus, caudally by the ventrolateral medullary depressor area, laterally by the spinal trigeminal nucleus, medially by the lateral edge of the inferior olive, and dorsally by the nucleus ambiguus. 724 Neurons located in the pressor area increase their discharge during cerebral ischemia, 6 and the cerebral ischemic response is abolished by electrolytic lesions in this region. 4 The transmitters mediating the cerebral ischemic response are not known. We have previously shown that the excitatory amino acids elicit pressor responses when injected into the pressor area. 22"24 It was, therefore, hypothesized that the cerebral ischemic response may be mediated by the release of these putative transmitters in this area. Supporting this hypothesis are reports stating that: 1) excitatory amino acids are involved in the pathophysiology of the central nervous system; j ~.~5 2) their extracellular concentrations are increased in brain ischemia; 2~ and 3) the administration of Nmethyl-D-aspartic acid (NMDA) as well as non-NMDA receptor antagonists protects the brain from injuries following cerebral ischemia. H2'~9 The object of this study was to investigate the role of excitatory amino acids and acetylcholine, which elicit pressor responses when injected into the pressor area, 2~ in mediating cardiovascular responses to experimentally induced global cerebral ischemia.
Materials and Methods

Animal Preparation
Male Wistar rats,* each weighing 300 to 350 gm, were used for the study. Anesthesia was induced with pentobarbital sodium (50 mg/kg) intraperitoneally, supplemented as necessary with further doses (10 mg/kg) intra-venously. The trachea was cannulated with polyethylene (PE)-240 tubing and the rats were artificially ventilated by means of a rodent respirator. One of the femoral arteries was cannulated with PE-50 tubing and the arterial pressure was monitored using a pressure transducer. Intravenous injections were delivered via a PE-50 venous cannula. The heart rate was monitored by a tachograph triggered by blood pressure waves. All tracings were recorded on a polygraph. The rectal temperature was monitored by a digital thermometer and maintained at 37 ~ + 0.5~
Ident~/ication of the Ventrolaleral Medullary Pressor Area
The animals were placed in the supine position in a stereotactic instrument and the ventral aspect of the occipital bone was exposed under an operating microscope. A bone window (7 x 6 mm) was created and the dura and arachnoid mater were opened separately. The pressor area was then functionally identified bilaterally by microinjections of L-glutamate (1.77 nmol/50 nl); the coordinates were: 3.4 mm rostral to the C-l vertebra, 1.7 to 1.9 mm lateral to the basilar artery, and 0.2 to 0.5 mm deep from the ventral surface of the brain stem.
Preparations for the microinjection were as follows. Single-barreled glass micropipettes were pulled to a tip diameter of 20 to 40 um using a vertical pipette puller. The blunt end of the micropipette was attached via PE-20 tubing to a microsyringe (1 ul) which was mounted on a computerized infusion pump.? The glass micropipette was then mounted on a micromanipulator. All solutions for microinjection were freshly prepared in normal saline and pH was adjusted to 7.4; the pH was 7.8 for the 6,7-dinitroquinoxaline-2,3-dione (DNQX) solution. All microinjections (50 to 100 nl) were delivered over a period of 5 seconds; the volume of injection, indicated by the displacement of the plunger in the graduated microsyringe, was visually confirmed under an operating microscope. Microinjections (50 to 100 nl) of normal saline (pH 7.4 to 7.8) served as controls.
ModelJbr Global Cerebral lschemia
The vertebral arteries were identified bilaterally at the C2-3 interspace and ligated with 6-0 silk suture. The carotid sinus nerves were identified bilaterally and sectioned.~7 Both common carotid arteries were exposed just caudal to the carotid bifurcation in preparation for simultaneous temporary occlusion with small aneurysm clips.
Chemical Agents
The following drugs were used: atropine sulfate; D-2-aminophosphonoheptanoate (AP-7); DNQX; L-glutamate monosodium; arginine vasopressin antagonist ( 1-(r acid), 2-(O-methyl)tyrosine) arginine vasopressin; j~ arginine vasopressin; muscimol (a ~/-aminohutyric acid receptor agonist); kainic acid; kynurenic acid; NMDA; and t Infusion pump, Model STC 100, obtained from Buxco Instruments, Sharon, Connecticut. quisqualic acid. The doses of agents microinjected into the brain stem refer to the salts.
Stalistical Analysis
A t-test for paired data (when the animals served as their own controls) and grouped data was used for assessing the significance of differences between mean values. Differences between various means were determined by analyses of variance followed by Duncan's multiple range test; the differences were considered significant at p < 0.05. All values are expressed as the mean _+ standard error of the mean, unless indicated otherwise,
Results
Validation of the Model Jot Global Cerebral Ischemia
Ligation of the vertebral arteries bilaterally did not alter the arterial pressure or heart rate. Subsequent bilateral occlusion of the carotid arteries of the 41 rats produced a cerebral ischemic response manifest as an increase in the mean arterial blood pressure (MABP, 60 _+ 4 mm Hg) and heart rate (27 + 4 beats/rain); data from all groups of pentobarbital-anesthetized rats were pooled to obtain these values. The baseline MABP and heart rate in these rats were 94 + 3 mm Hg and 328 + 8 beats/rain, respectively.
A duration of 1 minute was selected for studying these responses under steady-state conditions. In each of these experiments, the cerebral ischemic response was reproduced at least five times as long as a minimum interval of 5 minutes was allowed between tests. For example, in seven rats the increase in MABP (50 + 7 mm Hg) in the first cerebral ischemic response was not statistically different from that in the fifth response (47 _+ 5 mm Hg) elicited 2 hours later. Similarly, the increase in heart rate (19 + 7 beats/min) in the first cerebral ischemic response was not statistically different from that in the fifth response (15 + 5 beats/min).
When the rats were anesthetized intraperitoneally with a different anesthetic agent (urethane 1.5 gm/kg), the cerebral ischemic responses were similar to those observed in pentobarbital-anesthetized rats. For example, the increase in MABP in response to cerebral ischemia (62 _+ 14 mm Hg) in the three urethaneanesthetized rats was not significantly different from the response (50 _+ 7 mm Hg) in the seven pentobarbital-anesthetized rats.
Role of Vasopressin in the Global Cerebral Ischemic Response
In a group of four rats, arginine vasopressin receptors were blocked as follows: intravenous arginine vasopressin (120 ng/kg) elicited an increase in MABP (43 __+ 3 mm Hg) which was significantly reduced (5 +_ 2 mm Hg, p < 0.05) after an intravenous injection (1.84 #g/ kg) of an antagonist for these receptors (see "Chemical Agents" in Materials and Methods section). The antagonist did not alter the baseline MABP or heart rate. into the pressor area on both sides. A decrease in MAP (-42 + 9 mm Hg) resulted. C: The ischemic response, repeated after 9 minutes, was significantly reduced (p < 0.05). Between C and D (large arrow), 5% albumin (ALB) was infused (3 ml/3 rain, intravenously) to restore BP to control levels. D: The CIR remained significantly reduced (p < 0.05) even after the BP was restored. E: Bar graph showing significant reduction of the ischemic pressor responses by bilateral microinjections of MUS into the pressor area of the six rats in each group. CON (control) bar = increase in BP during ischemia; MUS bar = reduction in ischemic pressor response after injections of MUS into the pressor area: ALB bar = isehemic response when the BP was restored to control levels by infusions of ALB.
in MABP was 70 + 15 mm Hg before and 67 _+ 19 turn Hg after the injection of the antagonist. Likewise, the increase in heart rate induced by cerebral ischemia was 31 + 6 beats/rain before and 16 _+ 3 beats/rain after the injection of the antagonist.
Ventrolateral Medullary Pressor Area in Global Cerebral Ischemia
Microinjections of L-glutamate (1.77 nmol/50 nl) into the pressor area on each side elicited an increase in MABP (36 _+ 3 mm Hg) and heart rate (14 _+ 4 beats/ rain) (Fig. 1A) . Control injections of saline did not elicit a response. The cerebral ischemic response consisted of an increase in MABP (67 _+ 10 mm Hg) and heart rate (24 _+ 4 beats/min). In each experiment, after obtaining two comparable control cerebral ischemic responses (Fig. 1B) , muscimol (1 nmol/100 nl) was microinjected bilaterally into the previously identified pressor areas. The arterial pressure started to fall within 2 minutes and reached a steady state (-42 _+ 9 mm Hg) within 9 minutes. At this time, the increase in MABP (12 _+ 2 mm Hg) and heart rate (4 + 2 beats/rain) in response to the cerebral ischemia was significantly reduced (p < 0.05) when compared to the control cerebral ischemic response (Fig. 1C) . Next, the decrease in MABP caused by microinjections of muscimol into the pressor area was restored to near control levels by a slow intravenous infusion (1 ml/min for 3 minutes) of 5% albumin. The test for a cerebral ischemic response was repeated. The increase in MABP (12 _+ 2 mm Hg) remained significantly reduced (p < 0.05) and there was no change in heart rate (Fig. I D) .
Effects of Injections of Excitatory Amino Acids' into the Pressor Area
The following protocol was used for testing the effects of each excitatory amino acid mentioned in subsequent sections. The pressor area was identified unilaterally by microinjections of L-glutamate (1.77 nmol/50 nl). Fifteen minutes later, excitatory amino acid was injected into the same site and close dependent responses were recorded. The responses to all excitatory amino acids were elicited at least five times in each animal provided the interval between injections was at least 5 minutes. The dose of each excitatory amino acid that elicited maximum responses was selected for possible blockade of its effects by different doses of appropriate antagonists. The blocking effects of AP-7 (a specific NMDA receptor blocker), DNQX (a specific non-NMDA receptor blocker), and kynurenic acid (a broad-spectrum excitatory amino acid receptor blocker), whether used alone or in combination, lasted for 30 to 50 minutes. When the effects of these blockers were tested against an agonist, the latter was injected within 5 to 10 minutes.
Effect of NMDA. Microinjections of NMDA into the pressor area of four rats elicited a dose-dependent increase in MABP (Fig. 2A) . These responses could be blocked by prior injections of a specific NMDA blocker. The increases in MABP elicited by microinjections of 100 pmol NMDA into the pressor area after the injections of AP-7 at the same site were as follows (four rats in each group): 32 _+ 6 and 6 _+ 4 mm Hg (before and after 1 nmol AP-7, respectively; p < 0.05) and 31 _+ 8 and 3 _+ 1 mm Hg (before and after 2 nmol AP-7, respectively; p < 0.05). At a dose of 5 nmol, AP-7 completely blocked the responses to NMDA in four rats.
Effect of Quisqualate.
Quisqualate elicited dosedependent increases in MABP when injected into the pressor area of four rats (Fig. 2B) . Microinjections of 2 nmol DNQX (a specific non-NMDA receptor antagonist) into the pressor area significantly reduced (p < 0.05) the responses to I0 pmol quisqualate; the increase in MABP was 27 _+ 2 mm Hg before and 2 _+ 2 mm Hg after the injection of DNQX in three rats.
Effect ofKainate. Kainate elicited a dose-dependent increase in MABP when injected into the pressor area of four rats (Fig. 2C) . Microinjections of 2 nmol DNQX into the pressor area significantly reduced (p < 0.01) the responses to 10 pmol kainate. The increase in MABP induced by kainate in three rats was 33 _+ 2 mm Hg before the injection of DNQX, and there was no response after.
Effects of Excitatory Amino Acid Receplor Antagonists on Cerebral Ischemic Response
Effect of an NMDA Receptor Antagonist. The pressot area in four rats was identified bilaterally by microinjections of L-glutamate (Fig. 3A) . Baseline cerebral ischemic responses were then elicited (Fig. 3B) , and 1 nmol AP-7 was microinjected bilaterally into the pressor area. The increases in MABP in response to cerebral ischemia were not significantly different before (71 _+ 10 mm Hg) and after (75 _+ 8 mrn Hg) the injections of AP-7 into the pressor area (Fig. 3D) . Similarly, the increases in heart rate in response to cerebral ischemia were not significantly different before (41 _+ 5 beats/ rain) and after (41 _+ 8 beats/rain) the injections of AP-7 into the pressor area (Fig. 3C ). Effect of a Non-NMDA Receptor Antagonist. The pressor area was identified bilaterally in four rats by microinjections of L-glutamate (Fig. 4A) . Baseline cerebral ischemic responses were then elicited (Fig. 4B) , and 2 nmol DNQX was microinjected bilaterally into the pressor area. The increases in MABP in response to cerebral ischemia were not significantly different before (61 _+ 9 mm Hg) and after (69 -15 mm Hg) the injections of DNQX into the pressor area (Fig. 4D) . Also, the increases in heart rate in response to cerebral ischemia were not significantly different before (23 _+ 11 beats/rain) and after (24 _+ 9 beats/min) the injections of DNQX into the pressor area (Fig. 4C) . 
Effect of Simultaneous Blockade of NMDA and
Non-NMDA Receptors. The presser area was identified bilaterally in four rats by microinjections of L-glutamate (Fig. 5A) . Baseline cerebral ischemic responses were then elicited (Fig. 5B) , and 15 nmol kynurenic acid was microinjected bilaterally into the presser area. There was no significant alteration in the cerebral ischemic responses by the injection of kynurenic acid. The increases in MABP were 71 _+ 19 and 76 _+ 13 mm Hg before and after the injections of kynurenic acid into the presser area, respectively (Fig. 5D) . Likewise, the increases in heart rate before (39 _ 19 beats/rain) and after (39 + 15 beats/rain) the injections of kynurenic acid into the presser area were not significantly different (Fig. 5C ). Even a very high dose of kynurenic acid (15 nmol) failed to block the cerebral isehemie response. This dose of kynurenic acid was three times the dose needed for blocking the effects of the excitatory amino acid receptor agonists. For example, a 5-nmol injection of kynurenic acid significantly reduced (p < 0.05) the responses to the doses of NMDA, quisqualic acid, and kainic acid that elicited maximum responses. The increase in MABP before and after, respectively, the injection of 5 nmol kynurenic acid, in response: to 100 pmol NMDA was 67 + 11 and 2 _+ 2 mm Hg, to 10 pmol quisqualic acid was 25 + 0 and 7 _+ 3 mm Hg, and to 10 pmol kainic acid was 60 + 13 and 5 _+ 0 mm Hg (three rats in each group).
In another group of seven rats, 2 to 5 nine1 DNQX plus 1 to 16 nmol AP-7 were microinjected sequentially into the presser area on both sides. The presser area was previously identified bilaterally by microinjections of L-glutamate (Fig. 6A) . The cerebral ischemic response was elicited after the injection of excitatory amino acid receptor blockers into the presser area and compared to the control cerebral ischemic response ( Fig. 6B and C) . Combined injections of DNQX and AP-7 into the presser area did not significantly alter the cerebral ischemic response. In these experiments, the increases in MABP before (55 _+ 8 mm Hg) and after (57 _+ 13 mm Hg) the sequential injections of AP-7 and DNQX were not statistically different. Also, the increase in heart rate before (16 _+ 7 beats/min) and after (16 + 5 beats/rain) the injections of AP-7 plus DNQX were not significantly different.
Effect oJ" Atropine on the Cerebral Ischemic Response. The presser area was identified bilaterally in five rats by microinjections of L-glutamate. Baseline cerebral ischemic responses were then elicited, and 1 to 5 nmol atropine was microinjected bilaterally into the presser area. A decrease in the MABP (-43 + 5. I mm Hg) was observed, which lasted for 10 to 15 minutes. Microinjections of atropine into the presser area did not alter the cerebral ischemic responses significantly. The increase in MABP following cerebral ischemia was 53 + 7 and 52 + 14 mm Hg before and after injections of atropine, respectively. Similarly, the increases in heart rate before (27 +_ 7 beats/rain) and after (31 _+ 13 beats/min) the injections of atropine into the presser area were not statistically different.
Discussion
Animal Model
The rat was chosen as an experimental model for inducing global cerebral ischemia because the anatomy and physiology of central cardiovascular regulatory mechanisms have been studied extensively in this species. 7j4-'4 Cardiovascular responses to global cerebral ischemia were elicited in 100% of the animals and the responses were reproducible. Other investigators have reported a 90% success rate in producing global cerebral ischemia using a four-vessel occlusion technique; ~3 in these studies, the vertebral arteries may not have been occluded completely in the remaining 10% of rats. In our studies, the vertebral arteries were ligated under an operating microscope and the global cerebral ischemic response was obtained by subsequent temporary clamping of the carotid arteries. Ligation of the vertebral arteries did not alter the baseline blood pressure and heart rate because the hindbrain continued to receive blood from the spinal arteries as well as backflow from the circle of Willis. Carotid baroreceptors did not contribute to the pressor responses elicited because the carotid sinus nerves were sectioned bilaterally. '7 The contribution of arginine vasopressin in the pressor responses to cerebral ischemia was excluded because the intravenous injections of an arginine vasopressin antagonist failed to alter these responses. ~ The responses to cerebral ischemia were similar when the rats were anesthetized with a different anesthetic agent (urethane).
Role of Ventrolateral Medullary Pressor Area in Cerebral Ischemia Response
Electrolytic lesions in the pressor area abolish the pressor response to cerebral ischemia) a Based on this observation, it cannot be concluded that the cerebral ischemic response is mediated by the pressor area because electrol,vtic lesions destroy neurons as well as fibers of passage. In our study, the neurons in the pressor area were inhibited, without affecting the fibers of passage, by using microinjections of muscimol2 In each experiment, the pressor area was identified by microinjections of L-glutamate, which stimulates neuronal cell bodies but not fibers of passage? Inhibition of the neurons in the pressor area by microinjections of muscimol blocked the pressor responses to cerebral ischemia, lhus confirming that this area is indeed mediating these responses. Participation of other centers in the brain (such as the hypothalamus) cannot be ruled out. However, our results suggest that all pathways activated by cerebral ischemia must make their final synapse on the neurons in this pressor area in order to elicit these responses. The decrease in MABP caused by microinjections of muscimol into the pressor area was not responsible for the abolition of the cerebral ischemic response because when the blood pressure was restored to control levels by intravenous administration of albumin, the cerebral ischemic response was still blocked. Injections of albumin, in the absence of inhibition of the neurons in the pressor area by muscimol, did not alter the cerebral ischemic response.
Rob' of Excitatory Amino Acid and Cholinergic Receptors in Cerebral Ischemia
In order to test the possible release of excitatory amino acids as putative transmitters in the pressor area during global ischemia, it was necessary to investigate the presence of different subtypes of excitatory amino acid receptors in this region. Several subtypes of excitatory amino acid receptors have been identified in different regions of the central nervous system by eliciting responses to specific agonists (NMDA, amino-3-hydroxy-5-methyl-4-isoazole propionic acid (AMPA)/ quisqualate, and kainate).Z In our study, the presence of these receptor subtypes was demonstrated in the pressor area by eliciting sympathoexcitatory responses to the aforementioned agonists. No tachyphylaxis was observed with any of these agents provided that the interval between microinjections was at least 5 minutes. It is considered that AP-7 is a specific antagonist to NMDA while DNQX blocks non-NMDA receptors (kainate and AMPA/quisqualate). 2 Microinjection of l nmol AP-7 or 2 nmol DNQX alone into the pressor area did not block the cerebral ischemic response. These results suggested that specific blockade of NMDA or non-NMDA receptors alone was not sufficient to block the cerebral ischemic response. When a broad-spectrum blocker of excitatory amino acid receptors (kynurenate) was used, again the cerebral iscbemic response could not be blocked or attenuated. Complete blockade of the excitatory amino acid receptors was also attempted by combined injections of AP-7 and DNQX, and again these procedures did not affect the cerebral ischemic response. Complete blockade of excitatory amino acid receptors was ensured by the lack of responses to the appropriate agonists. For example, 1 nmol AP-7 blocked the response to 100 pmol NMDA; 2 nmol DNQX blocked the responses to 10 pmol kainic acid and 10 pmol quisqualic acid; and 5 nmol kynurenate blocked the responses to 100 pmol NMDA, 10 pmol kainic acid, and 10 pmol quisqualic acid. The aforementioned doses of NMDA, kainic acid, and quisqualic acid elicited maximum responses. Despite the blockade of one or all of these excitatory amino acid receptors, the cerebral ischemic response could not be blocked. It was, therefore, concluded that excitatory amino acid receptors do not mediate the pressor responses to cere-bral ischemia and that glutamate/aspartate may not be the transmitters released in the prcssor area. This conclusion is not in agreement with reports suggesting that the blockade of excitatory' amino acid receptors has a neuroprotective effect in experimental cerebral ischemia 'l'~5`'~e~ However, in the atbrementioned reports, reduction in neuronal damage in response to the cerebral ischemic response was observed following treatment with excitatory amino acid receptor blockers. Unlike the present investigation, physiological responses were not studied in these reports. It is, therefore, difficult to reconcile the differences between the results presented here and those of the other reports, t J~5 '"> Acetylcholine has also been implicated as an excitatory transmitter in the ventrolateral medulla~,' pressor area and its actions are mediated via M~ muscarinic receptors. 2~ These reports prompted us to investigate if this transmitter mediates the pressor responses during cerebral ischemic response. However, atropine failed to block the cardiovascular responses to cerebral ischemia, suggesting that acetylcholine is not the transmitter involved in these actions.
Conclusions
We have demonstrated that the integrity of the neurons located in the ventrolatoral medullary pressor area is necessary for eliciting cardiovascular sympathoexcitato~ responses to global cerebral ischemia. Despite the general notion that excitatory amino acids are involved in the cerebral ischemic response, ~~ ~~z'5'~ these results suggest that the release of an excitatory' transmitter (an amino acid or acetylcholine) in the pressor area does not mediate the cardiovascular responses to the global cerebral ischemia.
